Before the regulated market, Manzuri Law stood next to its clients in the battle for legality. As policy advisors to city and state officials during the beginning of the regulatory market, Manzuri Law has been instrumental in policy influence and elevating the local, state, and national conversation. Elevate your inbox and sign up to receive our monthly newsletter.
On September 21, 2020, the California Department of Food and Agriculture (CDFA) released its proposed Regulatory Plan for Hemp Production (the “Regulatory
On August 21, 2020, the Drug Enforcement Administration (DEA) published an interim final rule (IFR) to implement hemp-related amendments to the Federal
Meital Manzuri’s article “Bill Opens Bank Doors to Cannabis Operators (Read the Fine Print)” was published in the Los Angeles and
Our live Q&A on August 13th was a hit! We covered a variety of topics on how the new LA Ordinance and Fee Schedule
On July 29, 2020, a live resin vape cartridge customer filed a consumer class action in San Francisco Superior Court against cannabis
A new report commissioned by Weedmaps and the California Hispanic Chamber of Commerce estimates that California’s total taxable cannabis sales could reach
With multiple legislators contracting COVID-19, the Legislature recently confirmed that some voting will be done remotely in the next month. The new
Both consumers and members of the industry have been eagerly waiting for the FDA to provide clarity as to the regulatory future
The global pandemic and resulting economic turmoil have caused many businesses in the cannabis industry to teeter on the edge of insolvency.
The vertical integration model that LA MMJ businesses follow has been redefined by SB837. Read on to find out what this means
Last week DCR recommended the substantive changes to the ordinance which were accepted by City Council and the proposed ordinance (actual text to become
On June 15, 2020, California legislators passed their version of the 2020 state budget. It differs from the Governor’s May Revision, which
Written by: Hugh Mayo, J.D. Candidate 2021 In 2018, the FDA made waves when, for the first time, they issued a “Breakthrough Therapy”
Written by Kristen Abajian Welcome to a murky new movement to bring psychedelics out of the shadows and into a medical and
Yesterday, our office sent a letter to the City of Los Angeles describing the further delay and undue harm invoiced Phase 3 Round 1 Applicants would
Elevate your inbox. Sign up for our monthly newsletter for all things cannabis and hemp business law.
We use cookies and Google Analytics to analyze our website traffic and to understand where our visitors are coming from. By browsing our website, you consent to our use of cookies and Google Analytics. View our Privacy Policy and Terms of Use.
